Literature DB >> 28290130

The "Choosing Wisely" initiative in infectious diseases.

Clara Lehmann1,2, Reinhard Berner3, Johannes R Bogner4, Oliver A Cornely5,6,7, Katja de With8, Susanne Herold9, Winfried V Kern10, Sebastian Lemmen11, Mathias W Pletz12, Bernhard Ruf13, Bernd Salzberger14, Hans Jürgen Stellbrink15, Norbert Suttorp16, Andrew J Ullmann17, Gerd Fätkenheuer5,6, Norma Jung5.   

Abstract

OBJECTIVE: "Choosing Wisely" is a growing international campaign aiming at practice changes to improve patient health and safety by both, conduct of essential and avoidance of unnecessary diagnostic, preventive and therapeutic procedures. The goal is to create an easily recognizable and distributable list ("Choosing Wisely items") that addresses common over- and underuse in the management of infectious diseases.
METHODS: The German Society of Infectious Diseases (DGI) participates in the campaign "Klug Entscheiden" by the German Society of Internal Medicine. Committee members of the (DGI) listed potential 'Choosing Wisely items'. Topics were subjected to systematic evidence review and top ten items were selected for appropriateness. Five positive and negative recommendations were approved via individual member vote.
RESULTS: The final recommendations are: (1) Imperatively start antimicrobial treatment and remove the focus in Staphylococcus aureus bloodstream infection. (2) Critically ill patients with signs of infection need early appropriate antibiotic therapy. (3) Annual influenza vaccination should be given to individuals with age >60 years, patients with specific co-morbidities and to contact persons who may spread influenza to others. (4) All children should receive measles vaccine. (5) Prefer oral formulations of highly bioavailable antimicrobials whenever possible. (6) Avoid prescribing antibiotics for uncomplicated upper respiratory tract infections. (7) Do not treat asymptomatic bacteriuria with antibiotics. (8) Do not treat Candida detected in respiratory or gastrointestinal tract specimens. (9) Do not prolong prophylactic administration of antibiotics in patients after they have left the operating room. (10) Do not treat an elevated C-reactive protein (CRP) or procalcitonin with antibiotics for patients without signs of infection.
CONCLUSIONS: Physicians will reduce potential harm to patients and increase the value of health care when implementing these recommendations.

Entities:  

Keywords:  Choosing Wisely; Infectious diseases; Recommendations

Mesh:

Year:  2017        PMID: 28290130     DOI: 10.1007/s15010-017-0997-0

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  32 in total

Review 1.  Should we treat asymptomatic bacteriuria after renal transplantation?

Authors:  Julien Coussement; Daniel Abramowicz
Journal:  Nephrol Dial Transplant       Date:  2013-11-07       Impact factor: 5.992

2.  Choosing wisely--the politics and economics of labeling low-value services.

Authors:  Nancy E Morden; Carrie H Colla; Thomas D Sequist; Meredith B Rosenthal
Journal:  N Engl J Med       Date:  2014-01-22       Impact factor: 91.245

Review 3.  Clinical management of Staphylococcus aureus bacteremia: a review.

Authors:  Thomas L Holland; Christopher Arnold; Vance G Fowler
Journal:  JAMA       Date:  2014-10-01       Impact factor: 56.272

4.  ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

Authors:  O A Cornely; M Bassetti; T Calandra; J Garbino; B J Kullberg; O Lortholary; W Meersseman; M Akova; M C Arendrup; S Arikan-Akdagli; J Bille; E Castagnola; M Cuenca-Estrella; J P Donnelly; A H Groll; R Herbrecht; W W Hope; H E Jensen; C Lass-Flörl; G Petrikkos; M D Richardson; E Roilides; P E Verweij; C Viscoli; A J Ullmann
Journal:  Clin Microbiol Infect       Date:  2012-12       Impact factor: 8.067

5.  Preventing and controlling influenza with available interventions.

Authors:  Timothy M Uyeki
Journal:  N Engl J Med       Date:  2014-01-22       Impact factor: 91.245

6.  Antibiotics for asymptomatic bacteriuria.

Authors:  Anca Zalmanovici Trestioreanu; Adi Lador; May-Tal Sauerbrun-Cutler; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2015-04-08

Review 7.  Clinical management of Staphylococcus aureus bacteraemia.

Authors:  Guy E Thwaites; Jonathan D Edgeworth; Effrossyni Gkrania-Klotsas; Andrew Kirby; Robert Tilley; M Estée Török; Sarah Walker; Heiman Fl Wertheim; Peter Wilson; Martin J Llewelyn
Journal:  Lancet Infect Dis       Date:  2011-03       Impact factor: 25.071

8.  Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics.

Authors:  Adam L Hersh; Mary Anne Jackson; Lauri A Hicks
Journal:  Pediatrics       Date:  2013-11-18       Impact factor: 7.124

9.  Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies.

Authors:  Achim J Kaasch; Gavin Barlow; Jonathan D Edgeworth; Vance G Fowler; Martin Hellmich; Susan Hopkins; Winfried V Kern; Martin J Llewelyn; Siegbert Rieg; Jesús Rodriguez-Baño; Matthew Scarborough; Harald Seifert; Alex Soriano; Robert Tilley; M Estée Tőrők; Verena Weiß; A Peter R Wilson; Guy E Thwaites
Journal:  J Infect       Date:  2013-11-16       Impact factor: 6.072

10.  Antifungal therapy in patients with pulmonary Candida spp. colonization may have no beneficial effects.

Authors:  Simone Lindau; Manuel Nadermann; Hanns Ackermann; Tobias Michael Bingold; Christoph Stephan; Volkhard A J Kempf; Pia Herzberger; Andres Beiras-Fernandez; Kai Zacharowski; Patrick Meybohm
Journal:  J Intensive Care       Date:  2015-07-03
View more
  8 in total

1.  Optimizing Test Utilization in the Clinical Microbiology Laboratory: Tools and Opportunities.

Authors:  Bobbi S Pritt
Journal:  J Clin Microbiol       Date:  2017-09-27       Impact factor: 5.948

Review 2.  Essentials in the management of S. aureus bloodstream infection.

Authors:  N Jung; S Rieg
Journal:  Infection       Date:  2018-03-06       Impact factor: 3.553

Review 3.  [Infectious diseases - a specialty of internal medicine].

Authors:  G Fätkenheuer; N Jung; W V Kern; U R Fölsch; B Salzberger
Journal:  Internist (Berl)       Date:  2018-04       Impact factor: 0.743

4.  How can we teach medical students to choose wisely? A randomised controlled cross-over study of video- versus text-based case scenarios.

Authors:  Sascha Ludwig; Nikolai Schuelper; Jamie Brown; Sven Anders; Tobias Raupach
Journal:  BMC Med       Date:  2018-07-06       Impact factor: 8.775

5.  SOBRINA Spanish study-analysing the frequency, cost and adverse events associated with overuse in primary care: protocol for a retrospective cohort study.

Authors:  José Joaquín Mira; Irene Carrillo; María Teresa Gea Velázquez de Castro; Carmen Silvestre; Guadalupe Olivera; Johanna Caro-Mendivelso; Pastora Pérez-Pérez; Yolanda Agra; Ana Mª Fernández; Jesús Maria Aranaz-Andrés
Journal:  BMJ Open       Date:  2019-03-04       Impact factor: 2.692

6.  Practice Patterns of Infectious Diseases Physicians in Transitioning From Intravenous to Oral Therapy in Patients With Bacteremia.

Authors:  Duane R Hospenthal; C Dustin Waters; Susan E Beekmann; Philip M Polgreen
Journal:  Open Forum Infect Dis       Date:  2019-08-30       Impact factor: 3.835

7.  Better and fulfilling healthcare at lower costs: The need to manage health systems as complex adaptive systems.

Authors:  Joachim P Sturmberg; Johannes Bircher
Journal:  F1000Res       Date:  2019-06-05

8.  An Innovative Telemedical Network to Improve Infectious Disease Management in Critically Ill Patients and Outpatients (TELnet@NRW): Stepped-Wedge Cluster Randomized Controlled Trial.

Authors:  Kathrin Sperling; Robert Deisz; Gernot Marx; Wolfgang Greiner; Christian Juhra; Svenja Elkenkamp; Daniel Gensorowsky; Sebastian Lemmen; Jan Englbrecht; Sandra Dohmen; Antje Gottschalk; Miriam Haverkamp; Annette Hempen; Christian Flügel-Bleienheuft; Daniela Bause; Henna Schulze-Steinen; Susanne Rademacher; Jennifer Kistermann; Stefan Hoch; Hans-Juergen Beckmann; Christian Lanckohr; Volker Lowitsch; Arne Peine; Fabian Juzek-Kuepper; Carina Benstoem
Journal:  J Med Internet Res       Date:  2022-03-02       Impact factor: 5.428

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.